Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05075369
Other study ID # B2021 060
Secondary ID Karla Zuniga
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date October 2021
Est. completion date April 2022

Study information

Verified date September 2021
Source University of Manitoba
Contact Lisa Gould, MD, FRCS
Phone 204-957-3252
Email lisa.gould@umanitoba.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Disc hemorrhages are a known risk factor for progression of glaucoma. A positive water drinking test is also associated with progression of primary open glaucoma. The purpose of this study is to determine if patients with normal tension glaucoma and disc hemorrhages have a positive water drinking test. Patients with normal tension glaucoma and a disc hemorrhage will be recruited to undergo a water drinking test prior to any change in their treatment.


Description:

Patient with normal tension glaucoma under the care of a fellowship trained glaucoma specialist and noted to have a disc hemorrhage in one or both eyes when examined in the office will be recruited to undergo a water drinking test (WDT). After an informed consent is obtained, arrangements will be made to undergo the WDT either at the ophthalmologist's office or the local hospital clinic(Misericordia). The test will be administered in the following way: Upon arrival the patients baseline intraocular pressure (IOP) will be measured, then shortly afterwards the patient will drink 800 ml of water in a period of 5 minutes. Immediately after the water ingestion has finished a second IOP will be measured, followed by IOP measurements every 15 minutes for 60 minutes with a Goldman applanation tonometer by the same examiner. All of these measurements will be collected in a data sheet for the WTD. A total of 60 minutes would be the duration of the activity.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 20
Est. completion date April 2022
Est. primary completion date April 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - Clinical diagnosis of normal tension glaucoma by a fellowship trained glaucoma specialist, - Clinical diagnosis of a disc hemorrhage diagnosed by a fellowship trained glaucoma specialist, - Must be able to swallow water - Must be able to be positioned to allow accurate measurement of the Intraocular pressure with a slit lamp mounted Goldmann applanation tonometer - Must have a smooth corneal surface to allow for accurate Goldmann application tonometry measurement - Outpatient - A sufficient level of education to understand study procedures and be able to communicate with site personnel Exclusion Criteria: - History of refractive surgery, - Active ocular infection, - Pregnancy, - Cardiac or renal diseases, history of urinary retention, - Corneal abnormalities preventing reliable IOP measurements, - Previous trabeculectomy or glaucoma shunt surgery, - Previous laser iridotomy, - Cognitive impairment or language barrier preventing ability to provide an informed consent.

Study Design


Intervention

Diagnostic Test:
water drinking test
Water drinking test-glaucoma diagnostic test - marker for outflow facility reserve to detect IOP instability when the body ingests 800 ml of water within a 5 minute period of time

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Manitoba

References & Publications (3)

Ishida K, Yamamoto T, Sugiyama K, Kitazawa Y. Disk hemorrhage is a significantly negative prognostic factor in normal-tension glaucoma. Am J Ophthalmol. 2000 Jun;129(6):707-14. — View Citation

Susanna R Jr, Clement C, Goldberg I, Hatanaka M. Applications of the water drinking test in glaucoma management. Clin Exp Ophthalmol. 2017 Aug;45(6):625-631. doi: 10.1111/ceo.12925. Epub 2017 Mar 9. Review. — View Citation

Susanna R Jr, Vessani RM, Sakata L, Zacarias LC, Hatanaka M. The relation between intraocular pressure peak in the water drinking test and visual field progression in glaucoma. Br J Ophthalmol. 2005 Oct;89(10):1298-301. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in baseline intraocular pressure(IOP) with water drinking test The change in intraocular pressure in patients with normal tension glaucoma and a disc hemorrhage after undergoing the water drinking test will be measured with Goldmann applanation tonometry. A change from baseline IOP of 5 mm Hg is considered abnormal . The water drinking test takes 60 minutes, and the participant is then finished and can leave.
See also
  Status Clinical Trial Phase
Completed NCT01995136 - Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma Phase 4
Completed NCT00706056 - A New View of Normal Tension Glaucoma: Autoregulation and Systemic Blood Pressure N/A
Completed NCT01769521 - Relationship Between 24-hour IOP Pattern and the 24-hour Blood Pressure Pattern in Patients With POAG N/A
Recruiting NCT01446497 - Efficacy and Safety Study of Combigan and 0.5% Timoptic in Normal Tension Glaucoma Phase 4
Terminated NCT01864317 - Assessment of Optic Nerve Radiation in Patients With Glaucoma and Ocular Hypertension by 7 Tesla Diffusion Tensor Imaging Phase 2
Not yet recruiting NCT00739154 - Protective Effect of Phenytoin on Glaucoma N/A
Recruiting NCT03761992 - Measurement of the Effect of Gingko Biloba Extract on Ocular and Nailfold Blood-flow in NTG N/A
Recruiting NCT05371977 - Deep Sclerectomy Versus Trabeculectomy in Normal Tension Glaucoma N/A
Completed NCT03106532 - Evaluation of PHP-201 Ophthalmic Solution in Patients With Normal Tension Glaucoma Phase 2
Completed NCT01175902 - Intraocular Pressure and Ocular Perfusion Pressure of Cosopt in Normal Tension Glaucoma N/A
Completed NCT01488032 - Differences in Nerve Fiber Layer Between Patients With Normal- and High-Pressure-Glaucoma N/A
Completed NCT00570362 - Systemic Glutathione Level in Normal Tension Glaucoma N/A
Recruiting NCT06449352 - Effect of Netarsudil vs Brimonidine in NTG Patients on Latanoprost Phase 4
Not yet recruiting NCT06023927 - Obstructive Sleep Apnea as a Risk Factor for Normal Tension Glaucoma and a Crucial Step in Preventing Blindness
Completed NCT04475900 - Computer-aided Diagnosis of Ocular Diseases Based on Corneal Biomechanics
Completed NCT02863705 - Efficacy and Safety of COMBIGAN® in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG) Phase 4
Completed NCT00175786 - Magnetic Resonance Imaging of Patients With Normal Tension Glaucoma N/A
Completed NCT03323164 - Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study Phase 4
Completed NCT04014933 - Reproducibility of Blood Flowmetry in Human Retina Using the Nidek Laser Speckle Flowgraphy LSFG-NAVI System
Recruiting NCT01794442 - Study on the Oxygen Saturation in Pulsating and Non-pulsating Central Retinal Veins N/A